Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: June 28, 2017
What are the generic sources for atomoxetine hydrochloride and what is the scope of atomoxetine hydrochloride freedom to operate?
Atomoxetine hydrochloride is the generic ingredient in two branded drugs marketed by Lilly, Aurobindo Pharma Ltd, Zydus Pharms Usa Inc, Glenmark Pharms Ltd, Teva Pharms Usa, and Apotex Inc, and is included in six NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.| Tradenames: | 2 |
| Patents: | 2 |
| Applicants: | 6 |
| NDAs: | 6 |
| Drug Master File Entries: see list | 14 |
| Suppliers / Packagers: see list | 12 |
| Bulk Api Vendors: see list | 42 |
| Clinical Trials: see list | 2,345 |
| Patent Applications: see list | 1,907 |
| Therapeutic Class: | Central Nervous System Agents |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | atomoxetine hydrochloride at DailyMed |
| Drug Class | Norepinephrine Reuptake Inhibitor |
| Mechanism of Action | Norepinephrine Uptake Inhibitors |
| Applicant | Application No. | Strength | Dosage Form |
| ► Subscribe | ► Subscribe | 10MG | CAPSULE; ORAL |
| ► Subscribe | ► Subscribe | 100MG | CAPSULE; ORAL |
| ► Subscribe | ► Subscribe | 80MG | CAPSULE; ORAL |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Usa | ATOMOXETINE HYDROCHLORIDE | atomoxetine hydrochloride | CAPSULE;ORAL | 079022-007 | May 30, 2017 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Glenmark Pharms Ltd | ATOMOXETINE HYDROCHLORIDE | atomoxetine hydrochloride | CAPSULE;ORAL | 079019-002 | May 30, 2017 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Glenmark Pharms Ltd | ATOMOXETINE HYDROCHLORIDE | atomoxetine hydrochloride | CAPSULE;ORAL | 079019-004 | May 30, 2017 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Apotex Inc | ATOMOXETINE HYDROCHLORIDE | atomoxetine hydrochloride | CAPSULE;ORAL | 078983-004 | May 30, 2017 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Zydus Pharms Usa Inc | ATOMOXETINE HYDROCHLORIDE | atomoxetine hydrochloride | CAPSULE;ORAL | 079017-004 | Sep 17, 2010 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | STRATTERA | atomoxetine hydrochloride | CAPSULE;ORAL | 021411-004 | Nov 26, 2002 | 5,658,590*PED | ► Subscribe | ||||||||||||||||||||||
Lilly | STRATTERA | atomoxetine hydrochloride | CAPSULE;ORAL | 021411-006 | Nov 26, 2002 | 5,658,590*PED | ► Subscribe | ||||||||||||||||||||||
Lilly | STRATTERA | atomoxetine hydrochloride | CAPSULE;ORAL | 021411-001 | Nov 26, 2002 | 5,658,590*PED | ► Subscribe | ||||||||||||||||||||||
Lilly | STRATTERA | atomoxetine hydrochloride | CAPSULE;ORAL | 021411-003 | Nov 26, 2002 | 5,658,590*PED | ► Subscribe | ||||||||||||||||||||||
Lilly | STRATTERA | atomoxetine hydrochloride | CAPSULE;ORAL | 021411-007 | Feb 14, 2005 | 5,658,590*PED | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
Join the 21,741 other biopharmaceutical professionals who get our Drug Patent Expiration Alerts:
